Isotretinoin Plus Interferon in Treating Patients With Recurrent Cancer

Completed · Phase 2

Conditions studied: Cervical Cancer, Esophageal Cancer, Head and Neck Cancer, Lung Cancer, Non-melanomatous Skin Cancer, Penile Cancer

In brief

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of isotretinoin may be an effective way to prevent cancer or stop cancer from growing. Interferon alfa may interfere with the growth of cancer cells. Combining isotretinoin and interferon may be an effective treatment for some recurrent cancers. PURPOSE: Phase II trial to study the effectiveness of interferon alfa plus isotretinoin in treating patients with recurrent cancer.

Key facts

Study ID

NCT00002506

Run by

Hoag Memorial Hospital Presbyterian

Starts

1992-08-01

Expected to finish

1999-02-01

Last updated by the study team

2011-05-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Hoag Memorial Hospital Presbyterian — Newport Beach, California, United States
• Bloomington Hospital — Bloomington, Indiana, United States
• St. Vincent Hospital and Health Care Center — Indianapolis, Indiana, United States
• Bergan Mercy Medical Center — Omaha, Nebraska, United States
• Baptist Regional Cancer Center - Knoxville — Knoxville, Tennessee, United States
• St. Joseph Regional Cancer Center — Bryan, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.